Astro-Med Aktie

Astro-Med für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 922775 / ISIN: US04638F1084

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
05.06.2025 15:00:27

AstroNova Slips To Loss In Q1, Ad. EBITDA, Orders Climb, Backs FY26 Outlook; Stock Up In Pre-market

(RTTNews) - AstroNova, Inc. (ALOT), a data visualization technology company, reported Thursday a loss in its first quarter, compared to prior year's profit. Adjusted EBITDA, a key earnings metric, climbed from last year, with strong growth in revenues. Orders also were higher, and the firm maintained its fiscal 2026 outlook.

In the pre-market activity on the Nasdaq, AstroNova shares were gaining around 7.5 percent to trade at $9.80

The latest results included MTEX following its acquisition on May 6, which has been fully integrated into the Product Identification segment.

In the first quarter, net loss was $0.38 million or a loss of $0.05 per share, compared with net income of $1.18 million or $0.15 per share last year.

Adjusted net income was $0.35 million or $0.05 per share. There were no adjustments in the prior-year period.

Adjusted EBITDA of $3.15 million increased 27.6 percent from last year's $2.47 million. Adjusted EBITDA margin expanded 80 basis points year-over-year 8.3 percent.

Revenue grew 14.4 percent to $37.71 million from last year's $32.96 million.

Orders in the first quarter were $34.9 million, up from $33.1 million in 2025. The Company's order backlog was $25.5 million as of April 30, compared with $28.3 million at the end of fiscal 2025.

Looking ahead, for fiscal 2026, AstroNova continues to expect net revenue in the range of $160 million to $165 million, which is a 7 percent increase over fiscal 2025 at the mid-point of the range.

Adjusted EBITDA margin is expected to be in the range of 8.5 percent to 9.5 percent, an 80-basis point expansion over the prior year at the mid-point.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

Analysen zu Astro-Med Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Astro-Med Inc. 9,55 1,60% Astro-Med Inc.